NewAmsterdam Pharma N.V.
NAMS | NASDAQ
$20.09
+$0.03 (+0.15%)
Nov 2, 2026, 11:28 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -64.14M | -48.44M | -74.92M | 39.53M | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -49.5M | -46.09M | -38.29M | -42.02M | -38.04M | -4.78M | -1.17M | 1.38M | 929.7K | 1.73M | -1.3M | 2.82M |
Depreciation & Amortization | 59K | 62K | 59K | 64K | 45K | 52K | 51K | 28K | 19K | 15K | 13K | 6.15K | 13K | 9K | -13.15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 18.38M | n/a | n/a | 15.01M | 15.18M | 15.21M | 9.42M | n/a | 8.29M | 7.92M | 6.01M | 5.56M | 5.56M | 7.62M | 1.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 4.13M | -10.33M | 9.31M | -8.1M | -23.45M | 8.1M | -4.78M | -1.38M | -2.01M | -1.83M | -3.56M | 2.62M | -1.34M | 2.34M | -3.15M | 2.05M | 1.82M | -49.06K | 45.7K | 215.32K | -67.9K | 34.78K |
Other Non-Cash Items | 5.04M | 13.68M | 29.42M | -77.02M | -11.69M | -22.56M | 53.21M | 4.09M | -8.7M | 41.37M | 1.06M | 2.58M | 423K | 3.11M | 10.13M | 2.49M | -817.9K | -1.73M | -384.28K | -2.1M | 994.05K | -3.06M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.44M | 4.1M | 4.57M | -10.35M | -23.84M | 10.35M | -7.98M | 28K | -14.59M | -10.14M | 9.34M | 2.62M | 2.99M | -580K | 53.23M | 2.05M | 1.82M | -49.06K | 45.7K | 215.32K | -67.9K | 34.78K |
Operating Cash Flow | -39.21M | -30.6M | -40.88M | -32.77M | -37.67M | -36.47M | -37.48M | -12.5M | -53.98M | -54.6M | -33.07M | -35.32M | -29.31M | -31.86M | 27.22M | -239.9K | -172.6K | -393.68K | 591.13K | -153.91K | -373.14K | -202.46K |
Capital Expenditures | -80K | -38K | -100K | -42K | -88K | -16K | -3K | -75K | -209K | -385K | -3K | -9.35K | -5K | -7K | -109.43K | 5 | n/a | -5 | -5 | -3 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -51.18M | -62.47M | -71.54M | -31.85M | -183.71M | -9.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 46.5M | 51M | 50.5M | 34.4M | 24.66M | 12.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -62.18M | n/a | n/a | n/a | n/a | -2.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -4.76M | -11.51M | -21.14M | 2.51M | -159.14M | 2.86M | -62.18M | -75K | -209K | -385K | -3K | -2.6M | -5K | -7K | -109.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 6.52M | 1.59M | n/a | n/a | 7.7M | n/a | 198.76K | 6.33M | 2.39M | 156.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 11.04M | 11.07M | 13.68M | 5.89M | 3.43M | 6.52M | 456.61M | 58K | 4.66M | 198.18M | n/a | 198.76K | 6.33M | 2.39M | 156.9M | n/a | n/a | -45K | n/a | n/a | n/a | n/a |
Net Cash Flow | -33.44M | -32.38M | -48.39M | -24.15M | -184.56M | -23.32M | 349.01M | -7.98M | -50.44M | 140.7M | -27.86M | -32.65M | -24.61M | -26.42M | 467.73M | -239.9K | -172.6K | -438.68K | 591.13K | -153.91K | -373.14K | -202.46K |
Free Cash Flow | -39.29M | -30.64M | -40.98M | -32.81M | -37.76M | -36.48M | -37.48M | -12.58M | -54.19M | -54.99M | -33.08M | -35.33M | -29.31M | -31.87M | 29.08M | -239.89K | -172.6K | -393.68K | 591.12K | -153.91K | -373.14K | -202.46K |
Adj. Free Cash Flow | -57.68M | -30.64M | -40.98M | -47.82M | -52.94M | -51.7M | -46.9M | -12.58M | -62.48M | -62.91M | -39.08M | -40.89M | -34.87M | -39.49M | 27.16M | -239.89K | -172.6K | -393.68K | 591.12K | -153.91K | -373.14K | -202.46K |
Maintenance CapEx | -59K | -38K | -100K | -42K | n/a | -1.4K | n/a | n/a | -205.04K | -385K | -3K | -9.35K | -5K | -7K | -89.61K | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -21K | n/a | n/a | n/a | -88K | -14.6K | -3K | -75K | -3.96K | n/a | n/a | n/a | n/a | n/a | -19.82K | -5 | n/a | -5 | -5 | -3 | n/a | n/a |
Owner Earnings | -39.27M | -30.64M | -40.98M | -32.81M | -37.67M | -36.47M | -37.48M | -12.5M | -54.18M | -54.99M | -33.08M | -35.33M | -29.31M | -31.87M | 29.1M | -239.89K | -172.6K | -393.68K | 591.13K | -153.91K | -373.14K | -202.46K |
Add to Watchlist
Select watchlists to add or remove NAMS